RNA specialist Translate Bio is just weeks away from dosing the first patients in its phase 1/2 trial in cystic fibrosis patients after a green light from the FDA.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,